(Press-News.org) BOSTON – The global COVID-19 vaccination campaign saved an estimated 20 million lives. However, while current COVID-19 vaccines provide protection against developing severe disease, they do little to prevent infection and transmission.
Findings published in the journal Nature by physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) and colleagues suggest that it may be possible to improve protection against COVID-19 by delivering the vaccine directly to the respiratory tract— the primary site of entry in SARS-CoV-2 infection.
“The failure of the current generation of SARS-CoV-2 vaccines delivered by the intramuscular (IM) route to block infection likely relates to their inability to induce robust mucosal immune responses at the portal of entry,” said corresponding author Dan H. Barouch, MD, PhD, director of the Center for Vaccine and Virology Research at BIDMC. “In this study, we demonstrated that novel immunization strategies can markedly increase mucosal immunity in nonhuman primates and improve protective efficacy against a mucosal virus challenge.”
Barouch and colleagues primed 40 adult rhesus macaques with the Ad26 COVID-19 vaccine (Janssen/Johnson & Johnson) administered intramuscularly (IM)--like the shot in the arm adults typically receive. Approximately a year later, the animals received a booster. Three groups received either a dose of the Ad26 vaccine via the IM route, the intranasal (IN) route (delivered via nasal spray) or intratracheal (IT) route (delivered by nebulizer or inhaler). A fourth group received a dose of the bivalent mRNA vaccine (Pfizer-BioNTech) by the IN route. A sham group received no boosters.
When the macaques were later challenged with a high dose of the virus, the investigators sampled the animals’ blood, nasal and lung fluids to monitor their immune responses. They found that the Ad26 booster administered via the IT route provided near complete protection against a high-dose SARS-CoV-2 challenge and induced greater mucosal immunity than it did via the IN or IM route. In contrast, mRNA IN boosting proved ineffective, suggesting that improved formulations will likely be required for effective mucosal delivery of mRNA vaccines.
“Taken together, these data demonstrate that novel immunization strategies can markedly increase mucosal immunity in nonhuman primates and improve protective efficacy against a mucosal virus challenge,” said Barouch. “These data suggest the feasibility of developing vaccines that block respiratory viral infections.”
Co-authors included co-first authors Katherine McMahan, Malika Aid, Michaela Sciacca, Jinyan Liu, Nicole P. Hachmann, Jessica Miller, Catherine Jacob-Dolan, Olivia Powers and David Hope, as well as Cindy Wu, Juliana Pereira, Tetyana Murdza, Camille R. Mazurek and Amelia Hoyt of BIDMC; co-first author Frank Wegmann, as well as Jeroen Tolboom, Jan Serroyen, Laura Solforosi, Lea M.M. Costes, and co-senior author Roland C. Zahn of Janssen Vaccines and Prevention B.V.; Adrianus C.M. Boon of Washington University School of Medicine, Saint Louis; Meredith Davis-Gardner and Mehul S. Suthar of Emory School of Medicine; Amanda J. Martinot of Tufts University Cummings School of Veterinary Medicine; and Mona Boursiquot, Anthony Cook, Laurent Pessaint, Mark G. Lewis, Hanne Andersen of Bioqual.
This work was supported by Janssen, Gates Foundation (INV-027406, INV619 041469), National Institutes of Health (CA260476), the Massachusetts Consortium for Pathogen Readiness, and the Ragon Institute of MGH, MIT, and Harvard.
Barouch, Wegman, and Zahn are co-inventors on provisional SARS-CoV-2 vaccine patents 635 (63/121,482; 63/133,969; 63/135,182). Wegman, Tolboom, Serroyen, Solforosi, Costes and Zahn are employees and may hold equity in Janssen. The rest of the authors report no other conflict of interest.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.
Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,800 physicians and 38,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.
###
END
In the fatal world of opioid use disorder (OUD), pharmacotherapy, or using a prescribed medication to treat drug dependence, has emerged as the gold standard of treatment. Among the trio of FDA-approved medications to treat OUD, buprenorphine is the newest highly effective drug that can suppress and reduce cravings for opioids. It is also the first medication that physicians can prescribe without requiring a special waiver from the DEA, enabling outpatient use and substantially increasing treatment accessibility.
Despite its widespread usage, with 1 million buprenorphine prescriptions filled in 2018, it is not without side effects. When taken sublingually (under ...
Thursday Dec. 14, 2023, Toronto – Does thinking about faith make religious people more likely to take leaps? A new study lead by York University’s Faculty of Health says yes, finding that participants were more likely to take risks when thinking about God as a benevolent protector.
“While the theoretical link between a belief in God and risk taking has been around for a while, the methods previous studies employed to test this weren’t the strongest, based on current best ...
Dr. Aditya Bardia, a renowned breast medical oncologist and physician scientist who specializes in developing novel targeted and personalized therapies, has joined the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center where he will assume several leadership roles across the institution. These will include the directorship of the Breast Cancer Clinical and Research Programs and the position of assistant chief of Translational Research in the division of hematology/oncology, department of medicine. He will also be named director of Translational Research Integration and co-director ...
Research published today in Nature sheds light on a small part of the so-called “dark genome” — the 98 per cent of the human genome whose biological function is largely not known.
In the study, an international multidisciplinary team reported the first high-resolution images and structural details of a genetic element known as LINE-1 (video here), which inserts itself into the human genome and is implicated in diseases such as cancer, autoimmune disorders and neurodegeneration, and even aging. The work provides a target for ...
Quantum information scientists are always on the hunt for winning combinations of materials, materials that can be manipulated at the molecular level to reliably store and transmit information.
Following a recent proof-of-principle demonstration, researchers are adding a new combination of compounds to the quantum materials roster.
In a study reported in ACS Photonics, researchers combined two nanosized structures — one made of diamond and one of lithium niobate — onto a single chip. They then sent light from the diamond ...
In the frigid seas halfway between mainland Norway and the North Pole, two types of animals browse the palatable vegetation of a high-tundra archipelago, munching on thick moss, cropped grasses and low-lying shrubs. New research from a group led by Matteo Petit Bon from the Quinney College of Natural Resources is working to untangle the ecosystem impacts that two major players — geese and reindeer — have on a changing and vulnerable Arctic system.
Reindeer have been year-round residents on the islands of Svalbard for thousands of years, but at one point were almost completely gone. Svalbard ...
Hurricanes and other extreme weather events often affect disadvantaged communities more severely, and extended power outages are some of the most harmful effects. Concerns over the intensification of hurricanes has led to new environmental justice policies that aim to mitigate the unequal impacts of major storms. Now, policy experts and engineers are directing their attention toward illuminating the causes.
Researchers at the Georgia Institute of Technology sought to investigate whether socioeconomically vulnerable households experienced longer power outage durations after extreme weather events. The team analyzed data from the top eight major Atlantic hurricanes between 2017 ...
RICHLAND, Wash.—The Department of Energy’s Pacific Northwest National Laboratory has created the Center for AI @PNNL to coordinate the pioneering research of hundreds of scientists working on a range of projects focused on science, security and energy resilience.
Researchers at PNNL were among the first to dive into artificial intelligence decades ago. But AI has surged in the past year with the ready availability of generative AI, which allows almost anyone to produce sophisticated—though sometimes errant—text and images with just a small amount of data. At the same time, AI is a vital tool for ...
USD$200,000 awarded to tackle today’s pressing consumer technology demands
Utilizing smart optical sensors for IoT
Providing more realistic virtual and augmented realities
WASHINGTON – The Optica Foundation today released more detailed information on information technology research funded by the 2023 Optica Foundation Challenge. Researchers Zaijun Chen, University of Southern California, USA, and Alejandro Velez-Zea, Universidad de Antioquia, Colombia, both proposed novel approaches to addressing the flow of data and information in consumer-centric technologies.
“The ...
Certain facial features—like downturned lips and a heavy brow—are known to make someone appear untrustworthy to others, even though these do not indicate a person’s actual character. Such facial biases influence our everyday social interactions as well as high-stakes decisions, including who we hire, or elect to political office.
But a new study by Columbia researchers shows that the effects of these judgments can be mitigated. The study outlines the results of four experiments that the authors conducted with 1,400 volunteers. Through those experiments, the researchers found that when real-world defendants have facial features that appear untrustworthy, they are more likely ...
